Bb Biotech as of Sept. 30, 2017
Portfolio Holdings for Bb Biotech
Bb Biotech holds 27 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 12.8 | $464M | 3.2M | 145.82 | |
| Incyte Corporation (INCY) | 11.8 | $428M | 3.7M | 116.74 | |
| Ionis Pharmaceuticals (IONS) | 11.0 | $399M | 7.9M | 50.70 | |
| Gilead Sciences (GILD) | 6.2 | $225M | 2.8M | 81.02 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 6.2 | $224M | 1.5M | 152.04 | |
| Neurocrine Biosciences (NBIX) | 5.9 | $212M | 3.5M | 61.28 | |
| Radius Health | 5.9 | $212M | 5.5M | 38.55 | |
| Alexion Pharmaceuticals | 5.3 | $190M | 1.4M | 140.29 | |
| Agios Pharmaceuticals (AGIO) | 5.1 | $184M | 2.7M | 66.75 | |
| Halozyme Therapeutics (HALO) | 4.2 | $150M | 8.6M | 17.37 | |
| Alnylam Pharmaceuticals (ALNY) | 3.6 | $131M | 1.1M | 117.49 | |
| Tesaro | 3.6 | $129M | 996k | 129.10 | |
| Esperion Therapeutics (ESPR) | 2.9 | $105M | 2.1M | 50.12 | |
| Juno Therapeutics | 2.5 | $92M | 2.1M | 44.86 | |
| Regeneron Pharmaceuticals (REGN) | 2.5 | $92M | 205k | 447.12 | |
| Sage Therapeutics (SAGE) | 1.9 | $68M | 1.1M | 62.30 | |
| Myovant Sciences | 1.5 | $54M | 3.5M | 15.47 | |
| Macrogenics (MGNX) | 1.2 | $44M | 2.4M | 18.48 | |
| Avexis | 1.1 | $39M | 403k | 96.73 | |
| Intra Cellular Therapies (ITCI) | 1.0 | $35M | 2.2M | 15.78 | |
| Five Prime Therapeutics | 0.9 | $32M | 778k | 40.91 | |
| Intercept Pharmaceuticals In | 0.8 | $28M | 486k | 58.04 | |
| Alder Biopharmaceuticals | 0.8 | $28M | 2.3M | 12.25 | |
| Prothena (PRTA) | 0.6 | $23M | 350k | 64.77 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.3 | $11M | 1.3M | 8.10 | |
| Novavax | 0.3 | $9.5M | 8.3M | 1.14 | |
| Achillion Pharmaceuticals | 0.2 | $5.7M | 1.3M | 4.49 |
